SEARCH

SEARCH BY CITATION

References

  • 1
    Keniston R, Enriquez JI Sr. Relationship between blood pressure and plasma vitamin B6 levels in healthy middle-aged adults. Ann N Y Acad Sci. 1990;585:499501.
  • 2
    Aybak M, Sermet A, Ayyildiz MO, Karakilcik AZ. Effect of oral pyridoxine hydrochloride supplementation on arterial blood pressure in patients with essential hypertension. Arzneimittelforschung. 1995;45:12711273.
  • 3
    Paulose CS, Dakshinamurti K, Packer S, Stephens NL. Sympathetic stimulation and hypertension in the pyridoxine-deficient adult rat. Hypertension. 1988;11:387391.
  • 4
    Dakshinamurti K, Lal KJ, Ganguly PK. Hypertension, calcium channel and pyridoxine (vitamin B6). Mol Cell Biochem. 1998;2:137148.
  • 5
    Moline J, Bukharovich IF, Wolff MS, Phillips R. Dietary flavonoids and hypertension: is there a link? Med Hypotheses. 2000;55:306309.
  • 6
    Knekt P, Reunanen A, Järvinen R, et al. Antioxidant vitamin intake and coronary mortality in a longitudinal population study. Am J Epidemiol. 1994;139:11801189.
  • 7
    Karatzi KN, Papamichael CM, Karatizis EN, et al. Red wine acutely induces favorable effects on wave reflections and central pressures in coronary artery disease patients. Am J Hypertens. 2005;18:11611167.
  • 8
    Wong RH, Howe PR, Buckley JD, et al. Acute resveratrol supplementation improves flow-mediated dilatation in overweight obese individuals with mildly elevated blood pressure. Nutr Metab Cardiovasc Dis. 2011;21:851856.
  • 9
    Rivera L, Moron R, Zarzuelo A, Galisteo M. Long-term resveratrol administration reduces metabolic disturbances and lowers blood pressure in obese Zucker rats. Biochem Pharmacol. 2009;77:10531063.
  • 10
    Engelhard YN, Gazer B, Paran E. Natural antioxidants from tomato extract reduce blood pressure in patients with grade-1 hypertension: a double blind placebo controlled pilot study. Am Heart J. 2006;151:100.
  • 11
    Paran E, Novac C, Engelhard YN, Hazan-Halevy I. The effects of natural antioxidants from tomato extract in treated but uncontrolled hypertensive patients. Cardiovasc Durgs Ther. 2009;23:145151.
  • 12
    Reid K, Frank OR, Stocks NP. Dark chocolate or tomato extract for prehypertension: a randomized controlled trial. BMC Complement Altern Med. 2009;9:22.
  • 13
    Paran E, Engelhard Y. Effect of tomato's lycopene on blood pressure, serum lipoproteins, plasma homocysteine and oxidative stress markers in grade I hypertensive patients. Am J Hypertens. 2001;14:141A. Abstract P-333.
  • 14
    Hosseini S, Lee J, Sepulveda RT, et al. A randomized, double-blind, placebo-controlled, prospective 16 week crossover study to determine the role of pycnogenol in modifying blood pressure in mildly hypertensive patients. Nutr Res. 2001;21:12511260.
  • 15
    Zibadi S, Rohdewald PJ, Park D, Watson RR. Reduction of cardiovascular risk factors in subjects with type 2 diabetes by pycnogenol supplementation. Nutr Res. 2008;28:315320.
  • 16
    Liu X, Wei J, Tan F, et al. Pycnogenol French maritime pine bark extract improves endothelial function of hypertensive patients. Life Sci. 2004;74:855862.
  • 17
    Simons S, Wollersheim H, Thien T. A systematic review on the influence of trial quality on the effects of garlic on blood pressure. Neth J Med. 2009;67:212219.
  • 18
    Reinhard KM, Coleman CI, Teevan C, Vacchani P. Effects of garlic on blood pressure in patients with and without systolic hypertension: a meta-analysis. Ann Pharmacother. 2008;42:17661771.
  • 19
    Reid K, Frank OR, Stocks NP. Aged garlic extract lowers blood pressure in patients with treated but uncontrolled hypertension: a randomized controlled trial. Maturitas. 2010;67:144150.
  • 20
    Suetsuna K, Nakano T. Identification of an antihypertensive peptide from peptic digest of wakame (Undaria pinnatifida). J Nutr Biochem. 2000;11:450454.
  • 21
    Nakano T, Hidaka H, Uchida J, et al. Hypotensive effects of wakame. J Jpn Soc Clin Nutr. 1998;20:92.
  • 22
    Krotkiewski M, Aurell M, Holm G, et al. Effects of a sodium-potassium ion-exchanging seaweed preparation in mild hypertension. Am J Hypertens. 1991;4:483488.
  • 23
    Sato M, Oba T, Yamaguchi T, et al. Antihypertensive effects of hydrolysates of wakame (Undaria pinnatifida) and their angiotensin-1-converting inhibitory activity. Ann Nutr Metab. 2002;46:259267.
  • 24
    Sankar D, Sambandam G, Ramskrishna Rao M, Pugalendi KV. Modulation of blood pressure, lipid profiles and redox status in hypertensive patients taking different edible oils. Clin Chim Acta. 2005;2:97104.
  • 25
    Sankar D, Rao MR, Sambandam G, Pugalendi KV. Effect of sesame oil on diuretics or beta-blockers in the modulation of blood pressure, athropometry, lipid profile and redox status. Yale J Biol Med. 2006;79:1926.
  • 26
    Miyawaki T, Aono H, Toyoda-Ono Y, et al. Anti-hypertensive effects of sesamin in humans. J Nutr Sci Vitaminol (Toyko). 2009;55:8791.
  • 27
    Wichitsranoi J, Weerapreeyakui N, Boonsiri P, et al. Antihypertensive and antioxidant effects of dietary black sesame meal in pre-hypertensive humans. Nutr J. 2011;10:8288.
  • 28
    Sudhakar B, Kalaiarasi P, Al-Numair KS, et al. Effect of combination of edible oils on blood pressure, lipid profile, lipid peroxidative markers, antioxidant status, and electrolytes in patients with hypertension on nifedipine treatment. Saudi Med J. 2011;32:379385.
  • 29
    Sankar D, Rao MR, Sambandam G, Pugalendi KV. A pilot study of open label sesame oil in hypertensive diabetics. J Med Food. 2006;9:408412.
  • 30
    Nakano D, Ogura K, Miyakoshi M, et al. Antihyptensive effect of angiotensin–I-converting enzyme inhibitory peptides from a sesame protein hydrolysate in spontaneously hypertensive rats. Biosci Biotechnol Biochem. 2006;70:11181126.
  • 31
    Karatzi K, Stamatelopoulos K, Lykka M, et al. Acute and long-term hemodynamic effects of sesame oil consumption in hypertensive men. J Clin Hypertens (Greenwich). 2012;14:630636.
  • 32
    Mikhin VP, Kharchenko AV, Rosliakova EA, Cherniatina MA. Application of coenzyme Q(10) in combination therapy of arterial hypertension]. Kardiologiia. 2011;51:2631.
  • 33
    McMackin CJ, Widlansky ME, Hambury NM, Haung AL. Effect of combined treatment with alpha lipoic acid and acetyl carnitine on vascular function and blood pressure in patients with coronary artery disease. J Clin Hypertens. 2007;9:249255.
  • 34
    Salinthone S, Schillace RV, Tsang C, et al. Lipoic acid stimulates cAMP production via G protein-coupled receptor-dependent and –independent mechanisms. J Nutr Biochem. 2011;22:681690.
  • 35
    Rahman ST, Merchant N, Haque T, et al. The impact of lipoic acid on endothelial function and proteinuria in quinapril-treated diabetic patients with stage I hypertension: results from the QUALITY study. J Cardiovasc Pharmacol Ther. 2012;17:139145.
  • 36
    Morcos M, Borcea V, Isermann B, et al. Effect of alpha-lipoic acid on the progression of endothelial cell damage and albuminuria in patients with diabetes mellitus: an exploratory study. Diabetes Res Clin Pract. 2001;52:175183.
  • 37
    Hodgson JM, Puddey IB, Burke V, et al. Effects on blood pressure of drinking green and black tea. J Hypertens. 1999;17:457463.
  • 38
    Kurita I, Maeda-Yamamoto M, Tachibana H, Kamei M. Anti-hypertensive effect of Benifuuki tea containing O-methylated EGCG. J Agric Food Chem. 2010;58:19031908.
  • 39
    McKay DL, Chen CY, Saltzman E, Blumberg JB. Hibiscus sabdariffa L tea (tisane) lowers blood pressure in pre-hypertensive and mildly hypertensive adults. J Nutr. 2010;140:298303.
  • 40
    Bogdanski P, Suliburska J, Szulinska M, et al. Green tea extract reduces blood pressure, inflammatory biomarkers, and oxidative stress and improves parameters associated with insulin resistance in obese, hypertensive patients. Nutr Res. 2012;32:421427.
  • 41
    Hodgson JM, Woodman RJ, Puddey IB, et al. Short-term effects of polyphenol-rich black tea on blood pressure in men and women. Food Funct. 2013;4:111115.
  • 42
    Taubert D, Roesen R, Schomig E. Effect of cocoa and tea intake on blood pressure: a meta-analysis. Arch Intern Med. 2007;167:626634.
  • 43
    Taubert D, Roesen R, Lehmann C, et al. Effects of low habitual cocoa intake on blood pressure and bioactive nitric oxide: a randomized controlled trial. JAMA. 2007;298:4960.
  • 44
    Reid I, Sullivan T, Fakler P, et al. Does chocolate reduce blood pressure? A meta-analysis. BMC Med. 2010;8:3946.
  • 45
    Desch S, Kobler D, Schmidt J, et al. Low vs higher-dose dark chocolate and blood pressure in cardiovascular high-risk patients. Am J Hypertens. 2010;23:694700.
  • 46
    Desch S, Schmidt J, Sonnabend M, et al. Effect of cocoa products on blood pressure: systematic review and meta-analysis. Am J Hypertens. 2010;23:97103.
  • 47
    Ellinger S, Reusch A, Stehle P, Helfrich HP. Epicatechin ingested via cocoa products reduces blood pressure in humans: a nonlinear regression model with a Bayesian approach. Am J Clin Nutr. 2012;95:13651377.
  • 48
    Hooper L, Kay C, Abdelhamid A, et al. Effects of chocolate, cocoa, and flavan-3-ols on cardiovascular health: a systematic review and meta-analysis of randomized trials. Am J Clin Nutr. 2012;95:740751.
  • 49
    Yamaquchi T, Chikama A, Mori K, et al. Hydroxyhydroquinone-free coffee: a double-blind, randomized controlled dose-response study of blood pressure. Nutr Metab Cardiovasc Dis. 2008;18:408414.
  • 50
    Chen ZY, Peng C, Jiao R, et al. Anti-hypertensive nutraceuticals and functional foods. J Agric Food Chem. 2009;57:44854499.
  • 51
    Ochiai R, Chikama A, Kataoka K, et al. Effects of hydroxyhydroquinone-reduce coffee on vasoreactivity and blood pressure. Hypertens Res. 2009;32:969974.
  • 52
    Palatini P, Ceolotto G, Ragazzo F, et al. CYP 1A2 genotype modifies the association between coffee intake and the risk of hypertension. J Hypertens. 2008;27:15941601.
  • 53
    Scheer FA, Van Montfrans GA, van Someren EJ, et al. Daily nighttime melatonin reduces blood pressure in male patients with essential hypertension. Hypertension. 2004;43:192197.
  • 54
    Grossman E, Laudon M, Yalcin R, et al. Melatonin reduces night blood pressure in patients with nocturnal hypertension. Am J Med. 2006;119:898902.
  • 55
    Kozirog M, Poliwczak AR, Duchnowicz P, et al. Melatonin treatment improves blood pressure, lipid profile and parameters of oxidative stress in patients with metabolic syndrome. J Pineal Res. 2011;50:261266.
  • 56
    De-Leersnyder H, de Biois MC, Vekemans M, et al. Beta (1) adrenergic antagonists improve sleep and behavioural disturbances in a circadian disorder, Smith-Magenis syndrome. J Med Genet. 2001;38:58690.
  • 57
    Morand C, Dubray C, Milenkovic D, et al. Hesperidin contributes to the vascular protective effects of orange juice: a randomized crossover study in healthy volunteers. Am J Clin Nutr. 2011;93:7380.
  • 58
    Basu A, Penugonda K. Pomegranate juice: a heart-healthy fruit juice. Nutr Rev. 2009;67:4956.
  • 59
    Aviram M, Rosenblat M, Gaitine D, et al. Pomegranate juice consumption for 3 years by patients with carotid artery stenosis reduces common carotid intima-media thickness, blood pressure and LDL oxidation. Clin Nutr. 2004;23:423433.
  • 60
    Aviram M, Dornfeld L. Pomegranate juice inhibits serum angiotensin converting enzyme activity and reduces systolic blood pressure. Atherosclerosis. 2001;18:195198.
  • 61
    Feringa HH, Laskey DA, Dickson JE, Coleman CI. The effect of grape seed extract on cardiovascular risk markers: a meta-analysis of randomized controlled tirals. J Am Diet Assoc. 2011;111:11731181.
  • 62
    Sivaprakasapillai B, Edirsinghe K, Randolph J, et al. Effect of grape seed extract on blood pressure in subjects with the metabolic syndrome. Metabolism. 2009;58:17431746.
  • 63
    Edirisinghe I, Burton-Freeman B, Tissa Kappagoda C. Mechanism of the endothelium-dependent relaxation evoked by grape seed extract. Clin Sci (Lond). 2008;114:331337.
  • 64
    Rosenfeldt FL, Haas S, Krum H, Hadu A. Coenzyme Q 10 in the treatment of hypertension: a meta-analysis of the clinical trials. J Hum Hypertens. 2007;21:297306.
  • 65
    Burke BE, Neuenschwander R, Olson RD. Randomized, double-blind, placebo-controlled trial of coenzyme Q10 in isolated systolic hypertension. South Med J. 2001;94:11121117.
  • 66
    Tsai KL, Huang YH, Kao CL, et al. A novel mechanism of coenzyme Q10 protects against human endothelial cells from oxidative stress-induced injury by modulating NO-related pathways. J Nutr Biochem. 2012;23:458468.
  • 67
    Sohet FM, Delzenne NM. Is there a place for coenzyme Q in the management of metabolic disorders associated with obesity? Nutr Rev. 2012;70:631641.
  • 68
    Trimarco V, Cimmino CS, Santoro M, et al. Nutraceuticals for blood pressure control in patients with high-normal or grade 1 hypertension. High Blood Press Cardiovasc Prev. 2012;19:117122.
  • 69
    Young JM, Florkowski CM, Molyneux SL, et al. A randomized, double-blind, placebo-controlled crossover study of coenzyme Q10 therapy in hypertensive patients with the metabolic syndrome. Am J Hypertens. 2012;2:261270.
  • 70
    Martina V, Masha A, Gigliardi VR, et al. Long-term N-acetylcysteine and L-arginine administration reduces endothelial activation and systolic blood pressure in hypertensive patients with type 2 diabetes. Diabetes Care. 2008;31:940944.
  • 71
    Jiang B, Haverty M, Brecher P. N-acetyl-L-cysteine enhances interleukin-1beta-induced nitric oxide synthase expression. Hypertension. 1999;1:574579.
  • 72
    Vasdev S, Singal P, Gill V. The antihypertensive effect of cysteine. Int J Angiol. 2009;18:721.
  • 73
    Asher GN, Viera AJ, Weaver MA, et al. Effect of hawthorn standardized extract on flow mediated dilation in prehypertensive and mildly hypertensive adults: a randomized, controlled cross-over trial. BMC Complement Altern Med. 2012;12:26.
  • 74
    Walker AF, Marakis G, Simpson E, et al. Hypotensive effects of hawthorn for patients with diabetes taking prescription drugs: a randomised controlled trial. Br J Gen Pract. 2006;56:437443.
  • 75
    Walker AF, Marakis G, Morris AP, Robinson PA. Promising hypotensive effect of hawthorn extract: a randomized double-blind pilot study of mild, essential hypertension. Phytother Res. 2002;16:4854.
  • 76
    Larson A, Witman MA, Guo Y, et al. Acute, quercetin-induced reductions in blood pressure in hypertensive individuals are not secondary to lower plasma angiotensin-converting enzyme activity or endothelin-1: nitric oxide. Nutr Res. 2012;32:557564.
  • 77
    Edwards RL, Lyon T, Litwin SE, et al. Quercetin reduces blood pressure in hypertensive subjects. J Nutr. 2007;137:24052411.
  • 78
    Egert S, Bosy-Westphal A, Seiberl J, et al. Quercetin reduces systolic blood pressure and plasma oxidised low-density lipoprotein concentrations in overweight subjects with a high-cardiovascular disease risk phenotype: a double-blinded, placebo-controlled cross-over study. Br J Nutr. 2009;102:10651074.
  • 79
    Trovato A, Nuhlicek DN, Midtling JE. Drug-nutrient interactions. Am Fam Physician. 1991;44:16511658.
  • 80
    McCabe BJ, Frankel EH, Wolfe JJ, eds. Handbook of Food-Drug Interactions. Boca Raton, FL: CRC Press; 2003.
  • 81
    Houston MC. The role of cellular micronutrient analysis and minerals in the prevention and treatment of hypertension and cardiovascular disease. Ther Adv Cardiovasc Dis. 2010;4:v165v183.